BRYN MAWR TRUST Co - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 39 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRYN MAWR TRUST Co ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$215,000
+14.4%
14,0000.0%0.01%
+20.0%
Q4 2017$188,000
-20.3%
14,0000.0%0.01%
-28.6%
Q3 2017$236,000
+24.2%
14,0000.0%0.01%
+27.3%
Q2 2017$190,000
+52.0%
14,0000.0%0.01%
+37.5%
Q1 2017$125,000
+11.6%
14,0000.0%0.01%
+14.3%
Q4 2016$112,00014,0000.01%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders